| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1351216 | 6480464 | Ethinyl Estradiol affects the expression of RAPGEF3 mRNA | CTD | PMID:20170705 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1351216 | 6480464 | Ethinyl Estradiol results in decreased expression of RAPGEF3 mRNA | CTD | PMID:18936297 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of RAPGEF3 mRNA | CTD | PMID:20170705 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732974 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAPGEF3 mRNA | CTD | PMID:21570461 |
| aflatoxin B1 | increases expression | ISO | RGD:1351216 | 6480464 | Aflatoxin B1 results in increased expression of RAPGEF3 mRNA | CTD | PMID:21641981 |
| aflatoxin B1 | increases expression | ISO | RGD:1351216 | 6480464 | Aflatoxin B1 results in increased expression of RAPGEF3 mRNA | CTD | PMID:21641981 PMID:22100608 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RAPGEF3 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1351216 | 6480464 | Benzo(a)pyrene results in decreased expression of RAPGEF3 mRNA | CTD | PMID:22316170 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1351216 | 6480464 | RAPGEF3 protein promotes the reaction [Benzo(a)pyrene results in increased transport of Calcium] | CTD | PMID:22167199 |
| benzo[a]pyrene | increases response to substance | ISO | RGD:1351216 | 6480464 | RAPGEF3 protein results in increased susceptibility to Benzo(a)pyrene | CTD | PMID:22167199 |
| bisphenol A | affects expression | ISO | RGD:1351216 | 6480464 | bisphenol A affects the expression of RAPGEF3 mRNA | CTD | PMID:20170705 |
| bisphenol A | affects expression | ISO | RGD:1351216 | 6480464 | bisphenol A affects the expression of RAPGEF3 mRNA | CTD | PMID:20170705 PMID:22574217 |
| C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of RAPGEF3 mRNA | CTD | PMID:19167457 |
| calcium atom | multiple interactions | ISO | RGD:1351216 | 6480464 | RAPGEF3 protein promotes the reaction [Benzo(a)pyrene results in increased transport of Calcium] | CTD | PMID:22167199 |
| calcium(0) | multiple interactions | ISO | RGD:1351216 | 6480464 | RAPGEF3 protein promotes the reaction [Benzo(a)pyrene results in increased transport of Calcium] | CTD | PMID:22167199 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:732974 | 6480464 | Ciguatoxins affects the expression of RAPGEF3 mRNA | CTD | PMID:18353800 |
| cisplatin | multiple interactions | ISO | RGD:1351216 | 6480464 | RAPGEF3 affects the reaction [8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]] | CTD | PMID:21745194 |
| cisplatin | decreases response to substance | ISO | RGD:732974 | 6480464 | RAPGEF3 results in decreased susceptibility to Cisplatin | CTD | PMID:21745194 |
| cisplatin | multiple interactions | ISO | RGD:732974 | 6480464 | RAPGEF3 affects the susceptibility to [8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate results in decreased activity of Cisplatin]; more ... | CTD | PMID:21745194 |
| diazoxide | increases expression | ISO | RGD:732974 | 6480464 | Isoproterenol results in increased expression of RAPGEF3 mRNA | CTD | PMID:17557924 |
| diazoxide | increases response to substance | ISO | RGD:732974 | 6480464 | RAPGEF3 results in increased susceptibility to Isoproterenol | CTD | PMID:21745194 |
| diazoxide | multiple interactions | ISO | RGD:732974 | 6480464 | RAPGEF3 mutant form inhibits the reaction [Isoproterenol inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]] | CTD | PMID:21745194 |
| isoprenaline | increases expression | ISO | RGD:732974 | 6480464 | Isoproterenol results in increased expression of RAPGEF3 mRNA | CTD | PMID:17557924 |
| isoprenaline | increases response to substance | ISO | RGD:732974 | 6480464 | RAPGEF3 results in increased susceptibility to Isoproterenol | CTD | PMID:21745194 |
| isoprenaline | multiple interactions | ISO | RGD:732974 | 6480464 | RAPGEF3 mutant form inhibits the reaction [Isoproterenol inhibits the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]] | CTD | PMID:21745194 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1351216 | 6480464 | Diethylnitrosamine results in increased expression of RAPGEF3 mRNA | CTD | PMID:21527772 |
| paracetamol | affects expression | ISO | RGD:732974 | 6480464 | Acetaminophen affects the expression of RAPGEF3 mRNA | CTD | PMID:17562736 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of RAPGEF3 mRNA | CTD | PMID:19162173 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of RAPGEF3 mRNA | CTD | PMID:19013527 |
| scopolamine | decreases expression | EXP | | 6480464 | Scopolamine Hydrobromide results in decreased expression of RAPGEF3 mRNA | CTD | PMID:12818353 |
| valproic acid | increases expression | ISO | RGD:732974 | 6480464 | Valproic Acid results in increased expression of RAPGEF3 mRNA | CTD | PMID:21427059 |